Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 17, Number 2—February 2011

Dispatch

Pandemic (H1N1) 2009, Abu Dhabi, United Arab Emirates, May 2009–March 2010

Gulfaraz KhanComments to Author , Jamal Al-Mutawa, and Muhammad Jawad Hashim
Author affiliations: Author affiliations: United Arab Emirates University, Al Ain, United Arab Emirates (G. Khan, M.J. Hashim); Health Authority Abu Dhabi, Al Ain (J. Al-Mutawa)

Main Article

Table 2

Characteristics of 26 patients who died of pandemic (H1N1) 2009 infection, Abu Dhabi, United Arab Emirates, May 1, 2009–March 23, 2010

Characteristic Value
Gender, no. (%)
M 15 (59.7)
F
11 (42.3)
Nationality, no. (%)
United Arab Emirates 12 (46.2)
Expatriates
14 (53.8)
Age, y
Mean 43.8
Median 47.0
Range
0.67–83.00
Signs and symptoms, no. (%)
Fever 19 (73.1)
Cough 14 (53.8)
Breathing difficulty 14 (53.8)
Other,* with or without above symptoms
17 (65.4)
Underlying conditions, no. (%)
Pregnancy 6 (54.5)
Diabetes 9 (34.6)
Malignancy 7 (26.9)
Cardio/cerebrovascular disease 2 (7.7)
Hypertension 5 (19.2)
Asthma 2 (7.7)
Other 4 (15.4)
Not recorded
6 (23.1)
Duration of oseltamivir treatment, d†
Mean 8.3
Median 5.0
Range
2–28
Time from laboratory confirmation of pandemic (H1N1) 2009 infection to start of oseltamivir treatment, d‡
Mean −3.2
Median −2.0
Range
−16 to 2
Duration from hospitalization to death, d
Mean 27.5
Median 21
Range 1–86

*Sore throat, lung infiltration, diarrhea, headache, chest pain, abdominal pain.
†Although all patients with pandemic (H1N1) 2009 were treated with oseltamivir, the exact duration of treatment was known for only 12.
‡The exact date of laboratory confirmation of pandemic (H1N1) 2009 and start of oseltamivir treatment was known for only 21 of the 26 patients.

Main Article

TOP